License

FDCTech Signs the Definitive Agreement to Merge with Alchemy Group, Seeks Uplist

Retrieved on: 
Thursday, October 5, 2023

Irvine, CA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the definitive agreement with Alchemy Group where the Company acquired 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and 49.90% of Alchemy Markets Ltd. (Alchemy Malta). After the acquisition of 49.90% of Alchemy Malta, the Company will control 100.00% of all issued outstanding shares of Alchemy Malta. The acquisition of Alchemy UK and Alchemy Malta is subject to regulatory approval by the Financial Conduct Authority (FCA UK) and Malta Financial Services Authority (MFSA), respectively.

Key Points: 
  • The Company acquires 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and 49.90% of Alchemy Markets Ltd. (Alchemy Malta).
  • Irvine, CA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT ), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the definitive agreement with Alchemy Group where the Company acquired 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and 49.90% of Alchemy Markets Ltd. (Alchemy Malta).
  • After the acquisition of 49.90% of Alchemy Malta, the Company will control 100.00% of all issued outstanding shares of Alchemy Malta.
  • The acquisition of Alchemy UK and Alchemy Malta is subject to regulatory approval by the Financial Conduct Authority (FCA UK) and Malta Financial Services Authority (MFSA), respectively.

PurMinds(TM) NeuroPharma Awarded Synthetic Psilocybin API Import Permit from Health Canada to Develop GMP-Compliant Psychedelic Drug Product Formulations for Clinical Trial Supply

Retrieved on: 
Wednesday, October 11, 2023

PurMinds™ Dealer's License authorizes the production, formulation and global supply of psychedelic compounds, and the Company's newly awarded Import Permit allows for the legal importation of synthetic psilocybin active pharmaceutical ingredient (API) from PurMinds™ US-based API supplier to its Ontario-based neurolab and production facility.

Key Points: 
  • PurMinds™ Dealer's License authorizes the production, formulation and global supply of psychedelic compounds, and the Company's newly awarded Import Permit allows for the legal importation of synthetic psilocybin active pharmaceutical ingredient (API) from PurMinds™ US-based API supplier to its Ontario-based neurolab and production facility.
  • With MDMA therapy inching closer to receiving FDA approval, Alberta's regulation of psychedelic drugs for therapeutic use, and Australia's drug policy reform to reschedule MDMA and psilocybin, PurMinds™ anticipates a surge in the demand for investigatory psychedelic drug sales.
  • "These pivotal legislative reforms present a large growth opportunity for the Company that should greatly accelerate the pathway to positive cash flow," said Robin Shugar, J.D., Chief Commercial Officer and General Counsel.
  • "As one of the very few, licensed psychedelic mushroom cultivation and investigational drug product production facilities worldwide, and with a strong focus on safety, efficacy, and accessibility, PurMinds is ideally positioned to be at the forefront of clinical trial psychedelic drug product supply."

Get Ahead in the Transportation Equipment Industry with Detailed Company Profiles

Retrieved on: 
Wednesday, October 4, 2023

DUBLIN, Oct. 4, 2023 /PRNewswire/ -- The "Transportation Equipment Industry Database" database has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 4, 2023 /PRNewswire/ -- The "Transportation Equipment Industry Database" database has been added to ResearchAndMarkets.com's offering.
  • The Transportation Equipment Industry Database offers comprehensive profiles of various companies in the transportation equipment industry, including manufacturers, wholesalers, distributors, transportation and logistics firms, engineering and construction companies, and other industrial suppliers and service providers falling under the SIC Code 37 category.
  • Here are some key features and details about the database:
    Extensive Coverage: The database profiles 10,793 companies operating in the transportation equipment industry, making it a valuable resource for various purposes.
  • Overall, the Transportation Equipment Industry Database provides a comprehensive and valuable resource for businesses and professionals operating within or targeting the transportation equipment industry, offering detailed company profiles and executive contact information for various strategic purposes.

FDCTech Signs a Binding Letter of Intent to Merge with Alchemy Group

Retrieved on: 
Thursday, September 28, 2023

Irvine, CA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the legally binding agreement with Alchemy Group where the Company will acquire 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and the remaining 49.90% of Alchemy Markets Ltd. (Alchemy Malta), collectively known as Alchemy Group. The Company will issue 1,700,000 shares of its Series B Preferred stock, or such other number of shares that the parties agree upon to shareholder(s) of Alchemy Group, for the acquisition. Upon finalizing the merger, the existing management team and board of directors will continue to oversee and manage the Company's operations. This transaction is the result of extensive negotiations commencing in September 2022.

Key Points: 
  • The Company plans to acquire 100% of Alchemy Markets DMCC (UAE), 100% of Alchemy Prime Ltd. (UK), and the remaining 49.90% of Alchemy Markets Ltd. (Malta).
  • Irvine, CA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT ), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the legally binding agreement with Alchemy Group where the Company will acquire 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and the remaining 49.90% of Alchemy Markets Ltd. (Alchemy Malta), collectively known as Alchemy Group.
  • The combined expertise of FDCTech and the Alchemy Group can lead to operational efficiencies, cost savings, and the potential for innovative product and service offerings.
  • Please visit our SEC filings or the Company's website for more information on the full results, management's plan, and the binding letter of intent.

LithiumBank Announces Intellectual Property License Agreement with G2L Greenview Resources Inc. for Direct Lithium Extraction Technology, Pilot Plant Testing and Commercialization

Retrieved on: 
Monday, September 11, 2023

CALGARY, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) -- LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank'' or the “Company”) is pleased to announce it has entered into an intellectual property license agreement on September 8th 2023 (the “Agreement”) with G2L Greenview Resources Inc. (“G2L”), a subsidiary of Go2Lithium Inc., whereby G2L shall grant to the Company a license (the “License”) in Alberta and Saskatchewan for a full suite of continuous ion exchange technologies (the “Licensed Technology”). The Direct Lithium Extraction (“DLE”) technology will be used to extract lithium salts from enriched brines present at the Company’s lithium development projects.

Key Points: 
  • This update will include the G2L test work results and the effects of the Canadian federal government incentive tax credits for lithium brine processing.
  • G2L will also provide the Company with access to a deployment-ready pilot plant that has been previously operating in Australia.
  • Modifications to the pilot plant are almost complete and it is expected to be shipped in October to Alberta.
  • “This licensing agreement with G2L provides LithiumBank with access to best-in-class direct lithium extraction technology that we expect to have a significant impact on the economics of our Alberta projects,” said Paul Matysek, Executive Chairman of LithiumBank.

Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada

Retrieved on: 
Monday, September 11, 2023

Under the terms of the agreement, Planet 13 will have the exclusive manufacturing, sales and marketing rights for Ovation's topical / transdermal products for Nevada.

Key Points: 
  • Under the terms of the agreement, Planet 13 will have the exclusive manufacturing, sales and marketing rights for Ovation's topical / transdermal products for Nevada.
  • Planet 13 owns and operates the world's largest cannabis dispensary that has become a must-see destination for cannabis connoisseurs and tourists from around the world.
  • Planet 13 accounts for just under 9-percent of cannabis dispensary revenue for the entire state of Nevada.
  • "We are very pleased to reach this agreement with Planet 13, said Terry Howlett, President of Ovation.

Wolverine Worldwide Continues Brand Portfolio Transformation

Retrieved on: 
Friday, September 1, 2023

Wolverine World Wide, Inc. (NYSE: WWW) today announced additional steps in the ongoing transformation of its brand portfolio, including the sale of the Hush Puppies intellectual property in China, Hong Kong, and Macau, and the sale of the U.S. Wolverine Leathers business.

Key Points: 
  • Wolverine World Wide, Inc. (NYSE: WWW) today announced additional steps in the ongoing transformation of its brand portfolio, including the sale of the Hush Puppies intellectual property in China, Hong Kong, and Macau, and the sale of the U.S. Wolverine Leathers business.
  • “These transactions are the latest actions in our ongoing effort to reshape our portfolio and target our most meaningful opportunities,” said Mike Stornant, Executive Vice President and Chief Financial Officer of Wolverine Worldwide.
  • Wolverine will continue to own and operate the Hush Puppies brand throughout the rest of the world.
  • The Company assigned Wolverine’s U.S. tannery contracts to New Balance, and continues to explore alternatives for the non-U.S. Wolverine Leathers business.

Proton Capital Announces Strategic Alliance Agreement With PharmaChoice Canada Inc.

Retrieved on: 
Thursday, August 31, 2023

REGINA, Saskatchewan, Aug. 31, 2023 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton”) (PTN.P-TSX-V), further to its news releases dated April 20, 2023 and July 26, 2023 in relation to the signing of a Letter of Intent dated April 20, 2023 with PharmaChoice Canada Inc., and the potential qualifying transaction of Proton (“Qualifying Transaction”), Proton is pleased to report that the definitive agreements in relation to a strategic alliance (“Strategic Alliance Agreement”) with PharmaChoice Canada Inc. have been executed.

Key Points: 
  • REGINA, Saskatchewan, Aug. 31, 2023 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton”) (PTN.P-TSX-V), further to its news releases dated April 20, 2023 and July 26, 2023 in relation to the signing of a Letter of Intent dated April 20, 2023 with PharmaChoice Canada Inc., and the potential qualifying transaction of Proton (“Qualifying Transaction”), Proton is pleased to report that the definitive agreements in relation to a strategic alliance (“Strategic Alliance Agreement”) with PharmaChoice Canada Inc. have been executed.
  • In addition, the Strategic Alliance Agreement includes, but is not limited to, the following schedules which have been executed but are being held in escrow until the completion of the Qualifying Transaction: a license agreement (“License Agreement”), a right-of-first-refusal agreement (“ROFR”) and a master membership agreement (“Master Membership Agreement”).
  • Alan Simpson, CEO of Proton stated, “We are excited about our strategic alliance with PharmaChoice Canada Inc. and our entry into the pharmacy business upon completion of the Qualifying Transaction.
  • This strategic alliance provides long term sustainability for PharmaChoice Canada Inc. and its members and offers Proton a great pipeline of acquisitions for the foreseeable future.

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

Retrieved on: 
Thursday, August 31, 2023

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with two lead revolutionary product candidates in late-stage clinical development for reproductive health in addition to innovative diagnostic products constituting a broad portfolio of in-office accessible solutions, today announced that it has obtained a Medical Device Establishment License (“MDEL”) from Health Canada (License Number 24825).

Key Points: 
  • ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with two lead revolutionary product candidates in late-stage clinical development for reproductive health in addition to innovative diagnostic products constituting a broad portfolio of in-office accessible solutions, today announced that it has obtained a Medical Device Establishment License (“MDEL”) from Health Canada (License Number 24825).
  • The MDEL license is issued by Health Canada’s Regulatory Operations and Enforcement Branch (ROEB) to companies for the activities of manufacturing, importing and distributing and selling of medical devices for human use in Canada.
  • This license allows Femasys to directly sell its four products, FemaSeed®, FemVue®, FemCath® and FemCerv®, approved in Canada.
  • “We are thrilled to provide women in Canada access to Femasys’ medical products for infertility treatment and diagnosis, as well as cervical cancer diagnosis.”
    More information on Femasys’ approved products in Canada (FemaSeed, FemVue, FemCath and FemCerv) is below:

Excellence in Digital Commerce - Finding the Best in Class

Retrieved on: 
Wednesday, August 23, 2023

Looking at recent news highlights from some of the industry's recognized leaders, innovation and a passion for being best in class are driving growth for the sector.

Key Points: 
  • Looking at recent news highlights from some of the industry's recognized leaders, innovation and a passion for being best in class are driving growth for the sector.
  • Its mission is to streamline, simplify, digitize, and automate back-office financial processes while transforming digital payments through an all-in-one Fintech platform.
  • From the news: Fiserv was recognized in the Digital Payments Category for the depth and breadth of capabilities it provides merchants and financial institutions, including solutions that enable digital commerce, digital money transfers, and mobile payments.
  • For investors watching key trends, the banking industry is going through a digital transformation and evolution and the drive for excellence is in full gear.